Hagemeyer CE - Search Results

1

Fibrin-targeted direct factor Xa inhibition: construction and characterization of a recombinant factor Xa inhibitor composed of an anti-fibrin single-chain antibody and tick anticoagulant peptide.

Hagemeyer CE, Tomic I, Jaminet P, Weirich U, Bassler N, Schwarz M, Runge MS, Bode C, Peter K. Hagemeyer CE, et al. Thromb Haemost. 2004 Jul;92(1):47-53. doi: 10.1160/TH04-01-0047. Thromb Haemost. 2004. PMID: 15213844

2

Construction and characterization of a recombinant plasminogen activator composed of an anti-fibrin single-chain antibody and low-molecular-weight urokinase.

Hagemeyer CE, Tomic I, Weirich U, Graeber J, Nordt T, Runge MS, Bode C, Peter K. Hagemeyer CE, et al. J Thromb Haemost. 2004 May;2(5):797-803. doi: 10.1111/j.1538-7836.2004.00697.x. J Thromb Haemost. 2004. PMID: 15099287 Free article.

3

Conformation-specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets.

Schwarz M, Meade G, Stoll P, Ylanne J, Bassler N, Chen YC, Hagemeyer CE, Ahrens I, Moran N, Kenny D, Fitzgerald D, Bode C, Peter K. Schwarz M, et al. Among authors: hagemeyer ce. Circ Res. 2006 Jul 7;99(1):25-33. doi: 10.1161/01.RES.0000232317.84122.0c. Epub 2006 Jun 15. Circ Res. 2006. PMID: 16778135

4

Single-chain antibodies as new antithrombotic drugs.

Hagemeyer CE, Schwarz M, Peter K. Hagemeyer CE, et al. Semin Thromb Hemost. 2007 Mar;33(2):185-95. doi: 10.1055/s-2007-969033. Semin Thromb Hemost. 2007. PMID: 17340468 Review.

5

Single-chain antibodies as diagnostic tools and therapeutic agents.

Hagemeyer CE, von Zur Muhlen C, von Elverfeldt D, Peter K. Hagemeyer CE, et al. Thromb Haemost. 2009 Jun;101(6):1012-9. Thromb Haemost. 2009. PMID: 19492141 Review.

6

HMGB1 binds to activated platelets via the receptor for advanced glycation end products and is present in platelet rich human coronary artery thrombi.

Ahrens I, Chen YC, Topcic D, Bode M, Haenel D, Hagemeyer CE, Seeba H, Duerschmied D, Bassler N, Jandeleit-Dahm KA, Sweet MJ, Agrotis A, Bobik A, Peter K. Ahrens I, et al. Among authors: hagemeyer ce. Thromb Haemost. 2015 Nov;114(5):994-1003. doi: 10.1160/TH14-12-1073. Epub 2015 Jul 23. Thromb Haemost. 2015. PMID: 26202300

7

Platelet-targeted dual pathway antithrombotic inhibits thrombosis with preserved hemostasis.

Hanjaya-Putra D, Haller C, Wang X, Dai E, Lim B, Liu L, Jaminet P, Yao J, Searle A, Bonnard T, Hagemeyer CE, Peter K, Chaikof EL. Hanjaya-Putra D, et al. Among authors: hagemeyer ce. JCI Insight. 2018 Aug 9;3(15):e99329. doi: 10.1172/jci.insight.99329. eCollection 2018 Aug 9. JCI Insight. 2018. PMID: 30089712 Free PMC article.

8

Targeting ligand-induced binding sites on GPIIb/IIIa via single-chain antibody allows effective anticoagulation without bleeding time prolongation.

Stoll P, Bassler N, Hagemeyer CE, Eisenhardt SU, Chen YC, Schmidt R, Schwarz M, Ahrens I, Katagiri Y, Pannen B, Bode C, Peter K. Stoll P, et al. Among authors: hagemeyer ce. Arterioscler Thromb Vasc Biol. 2007 May;27(5):1206-12. doi: 10.1161/ATVBAHA.106.138875. Epub 2007 Feb 22. Arterioscler Thromb Vasc Biol. 2007. PMID: 17322097

9

Ex-vivo thrombolytic gene therapy for vein graft patency: the frontier for development of selective, localised therapeutic approaches.

Hagemeyer CE, Peter K. Hagemeyer CE, et al. Thromb Haemost. 2009 Jul;102(1):3-4. doi: 10.1160/TH09-06-0343. Thromb Haemost. 2009. PMID: 19572059 No abstract available.

10

[Helping antibodies. Targeted antithrombotic and fibrinolytic therapy].

Schwarz M, Hagemeyer CE, Peter K, Bode C. Schwarz M, et al. Among authors: hagemeyer ce. Hamostaseologie. 2007 Dec;27(5):360-2. Hamostaseologie. 2007. PMID: 18060247 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters